JP5524829B2 - 半径方向の高い強度を備えたステントおよびその製造方法 - Google Patents
半径方向の高い強度を備えたステントおよびその製造方法 Download PDFInfo
- Publication number
- JP5524829B2 JP5524829B2 JP2010506710A JP2010506710A JP5524829B2 JP 5524829 B2 JP5524829 B2 JP 5524829B2 JP 2010506710 A JP2010506710 A JP 2010506710A JP 2010506710 A JP2010506710 A JP 2010506710A JP 5524829 B2 JP5524829 B2 JP 5524829B2
- Authority
- JP
- Japan
- Prior art keywords
- ring
- struts
- stent
- degrees
- polymer tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- 229920000642 polymer Polymers 0.000 claims description 122
- 238000002788 crimping Methods 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 23
- 230000007704 transition Effects 0.000 claims description 8
- 239000000758 substrate Substances 0.000 description 27
- 238000005452 bending Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 229920002988 biodegradable polymer Polymers 0.000 description 6
- 239000004621 biodegradable polymer Substances 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000000071 blow moulding Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229920001432 poly(L-lactide) Polymers 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- -1 vinyl halide Chemical class 0.000 description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 210000000013 bile duct Anatomy 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000011733 molybdenum Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 208000037804 stenosis Diseases 0.000 description 3
- 230000036262 stenosis Effects 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229920006125 amorphous polymer Polymers 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 239000010952 cobalt-chrome Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000003698 laser cutting Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000307 polymer substrate Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 229920006126 semicrystalline polymer Polymers 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229910000599 Cr alloy Inorganic materials 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 229920006370 Kynar Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910001182 Mo alloy Inorganic materials 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 1
- 229920001077 Poly(N-acetyl glucosamine) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229920006220 SOLEF 21508 PVDF Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 229920001893 acrylonitrile styrene Polymers 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229920006218 cellulose propionate Polymers 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229920000359 diblock copolymer Polymers 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 description 1
- 125000002573 ethenylidene group Polymers [*]=C=C([H])[H] 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 210000002989 hepatic vein Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 1
- 229920001693 poly(ether-ester) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920006211 poly(glycolic acid-co-trimethylene carbonate) Polymers 0.000 description 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 1
- 229920001849 poly(hydroxybutyrate-co-valerate) Polymers 0.000 description 1
- 229920000218 poly(hydroxyvalerate) Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 239000002745 poly(ortho ester) Substances 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920006219 poly(vinylidene fluoride-co-hexafluoropropene) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920006216 polyvinyl aromatic Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920001290 polyvinyl ester Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 229920006215 polyvinyl ketone Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C67/00—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00
- B29C67/0014—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00 for shaping tubes or blown tubular films
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91566—Adjacent bands being connected to each other connected trough to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2793/00—Shaping techniques involving a cutting or machining operation
- B29C2793/0009—Cutting out
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C53/00—Shaping by bending, folding, twisting, straightening or flattening; Apparatus therefor
- B29C53/02—Bending or folding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C55/00—Shaping by stretching, e.g. drawing through a die; Apparatus therefor
- B29C55/22—Shaping by stretching, e.g. drawing through a die; Apparatus therefor of tubes
- B29C55/24—Shaping by stretching, e.g. drawing through a die; Apparatus therefor of tubes radial
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
- B29L2031/7534—Cardiovascular protheses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49908—Joining by deforming
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Description
RE=(拡張したチューブの外径、ODE)/(チューブの元の内径、IDO)
RE比率はまた、次のようにパーセント拡張としても表わすことができる:
%RE=(RE−1)×100%
Claims (24)
- ポリマーチューブの半径方向の強度を増加させるために径方向に前記ポリマーチューブを変形させる工程;および
変形した前記ポリマーチューブから直線状のリングストラットおよび湾曲したヒンジ要素を形成する工程を備え;
前記リングストラットは前記ヒンジ要素によって互いに接続され、前記リングストラットおよび前記ヒンジ要素は複数のリングを画成し、前記ヒンジ要素は前記リングの非変形形態から変形形態への移行を可能にするように適応し、
前記非変形形態は、クリンプされる前の前記リングの状態に対応し、前記変形形態はクリンプを行なった後の前記リングの状態に対応し、前記リングストラットは、前記リングが非変形形態にあるときに、100度を超える内角で互いに対して配向され、
各リングが中心点を有し、少なくとも前記2つの中心点が中心軸を定義し、前記リングをともに接続する連結ストラットを形成する工程をさらに備え、
前記連結ストラットは前記中心軸に平行かまたは実質的に平行に配向され、ここで前記リングストラット、前記ヒンジ要素、および前記連結ストラットは複数のW形状のクローズドセルを画成し、各W形状のセルは6個の他のW形状のセルに接し、各W形状のセルは8つの前記リングストラット、2つの前記連結ストラット、および10個の前記ヒンジ要素を含む周囲部を有する、
内部人工器官を作製する方法。 - 前記リングが非変形形態にあるときに、前記内角が約124度〜約130度の間である、
請求項1に記載の方法。 - 径方向への変形後の前記ポリマーチューブの外径が、径方向の変形前の前記ポリマーチューブの内径の約5倍以上となる、
請求項1又は請求項2に記載の方法。 - 径方向への変形後の前記ポリマーチューブの外径が、径方向の変形前の前記ポリマーチューブの内径の約6倍以上となる、
請求項1又は請求項2に記載の方法。 - 各リングストラットが、前記リングが非変形形態にあるときに、前記ポリマーチューブが径方向に変形された方向に対して約40度未満の0でない角度で配向される、
請求項1乃至請求項4のいずれか1項に記載の方法。 - 直線状のリングストラットと湾曲したヒンジ要素を備え、
前記リングストラットは前記ヒンジ要素によって互いに接続され、前記リングストラットおよび前記ヒンジ要素は複数のリングを画成し、前記ヒンジ要素は前記リングの非変形形態から変形形態までの移行可能にするように適応し、
前記非変形形態は、クリンプされる前の前記リングの状態に対応し、前記変形形態はクリンプを行なった後の前記リングの状態に対応し、前記リングストラットは、前記リングが非変形形態にあるときに、100度を超える内角で互いに対して配向され、
前記リングストラットおよび前記ヒンジ要素が径方向に拡張されたポリマーチューブから形成され、
各リングが中心点を有し、少なくとも前記2つの中心点が中心軸を定義し、前記リングをともに接続する連結ストラットをさらに備え、前記連結ストラットは前記中心軸に平行かまたは実質的に平行に配向され、ここで前記リングストラット、前記ヒンジ要素、および前記連結ストラットは複数のW形状のクローズドセルを画成し、各W形状のセルは6個の他のW形状のセルに接し、各W形状のセルは8つの前記リングストラット、2つの前記連結ストラット、および10個の前記ヒンジ要素を含む周囲部を有する、
内部人工器官。 - 前記リングが非変形形態にあるときに、前記内角が、約124度〜約130度の間である、
請求項6に記載の内部人工器官。 - 前記径方向に拡張されたポリマーチューブは拡張前の前記チューブの内径の約5倍以上の外径を有する、
請求項6又は請求項7に記載の内部人工器官。 - 前記径方向に拡張されたポリマーチューブは拡張前の前記チューブの内径の約6倍以上の外径を有する、
請求項6又は請求項7に記載の内部人工器官。 - 各リングストラットが、前記リングが非変形形態にあるときに、前記のポリマーチューブが径方向に変形された方向に対して約40度未満の角度で配向される、
請求項6乃請求項9のいずれか1項に記載の内部人工器官。 - 拡張後のポリマーチューブの外径が拡張前の前記ポリマーチューブの内径の約4倍よりも大きいように、径方向に前記ポリマーチューブを拡張する工程;と
リングストラットおよび連結ストラットを径方向に拡張した前記ポリマーチューブから形成する工程を備え;
前記リングストラットは非変形形態から変形形態まで移行可能な複数のリングを画成し、各リングは中心点を有し、少なくとも2つの前記中心点が中心軸を定義し、前記連結ストラットは前記中心軸に平行かまたは実質的に平行に配向されて前記リングをともに接続し、前記連結ストラットおよび前記リングストラットはW形状のクローズドセルを画成し、各W形状のセルは6つの他のW形状のセルに接し、
前記非変形形態は、クリンプされる前の前記リングの状態に対応し、前記変形形態はクリンプを行なった後の前記リングの状態に対応し、前記リングストラットは、前記リングが非変形形態にあるときに、100度を超える内角で互いに対して配向される、
内部人工器官を作製する方法。 - 前記リングが非変形形態にあるときに、前記内角が約124度〜約130度の間である、
請求項11に記載の方法。 - 拡張後の前記ポリマーチューブの外径が、拡張前の前記ポリマーチューブの内径の約6倍以上である、
請求項11又は請求項12に記載の方法。 - 各リングストラットが、前記リングが非変形形態にあるときに、前記径方向の拡張の方向に対して約25度〜約28度の間の角度で配向される、
請求項11乃至請求項13のいずれか1項に記載の方法。 - 前記リングが非変形形態にあるときに、各リング上の前記リングストラットが、互いに交互に現れる一連のクレストおよびトラフを画成し、各リング上の各クレストは前記連結ストラットの1つによって他のリング上の他のクレストに接続される、
請求項11乃至請求項14のいずれか1項に記載の方法。 - 拡張前のポリマーチューブの内径の約4倍よりも大きい拡張後の外径を有する径方向に拡張された前記ポリマーチューブから形成されたリングストラットおよび連結ストラットを備え;
前記リングストラットは非変形形態から変形形態まで移行可能な複数のリングを画成し、各前記リングは中心点を有し、少なくとも2つの前記中心点が中心軸を定義し、前記連結ストラットは前記中心軸に平行かまたは実質的に平行に配向されて前記リングをともに接続し、前記連結ストラットおよび前記リングストラットはW形状のクローズドセルを画成し、各W形状のセルは6つの他のW形状のセルに当接し、
前記非変形形態は、クリンプされる前の前記リングの状態に対応し、前記変形形態はクリンプを行なった後の前記リングの状態に対応し、前記リングストラットは、前記リングが非変形形態にあるときに、100度を超える内角で互いに対して配向される、
内部人工器官。 - 前記リングが非変形形態にあるときに、前記内角が約124度〜約130度の間である、
請求項16に記載の内部人工器官。 - 拡張後の前記ポリマーチューブの外径が、拡張前の前記ポリマーチューブの内径の約6倍以上である、
請求項16又請求項17に記載の内部人工器官。 - 各リングストラットが、前記リングが非変形形態にあるときに、前記中心軸に垂直な平面に対して約25度〜約28度の間の角度で配向される、
請求項16乃至請求項18のいずれか1項に記載の内部人工器官。 - 前記の連結ストラットおよびリングストラットの長さが、等しいか実質的に等しい、
請求項16乃至請求項19のいずれか1項に記載の内部人工器官。 - 前記リングが非変形形態にあるときに、各リング上の前記リングストラットが、お互いに交互に現れる一連のクレストおよびトラフを画成し、各リング上の各クレストは前記連結ストラットの1つによって他のリング上の他のクレストに接続される、
請求項16乃至請求項20のいずれか1項に記載の内部人工器官。 - 前記ポリマーチューブが、外面および内面を有し、前記リングは反管腔表面および管腔表面を有し、前記反管腔表面は前記ポリマーチューブの前記外面に対応し、前記管腔表面は前記ポリマーチューブの前記内面に対応する、
請求項16乃至請求項21のいずれか1項に記載の内部人工器官。 - 前記W形状のセルが、円周方向でサイズが変化する、
請求項16乃至請求項22のいずれか1項に記載の内部人工器官。 - 前記W形状のセルが、前記軸方向でサイズが変化する、
請求項16乃至請求項23のいずれか1項に記載の内部人工器官。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92778507P | 2007-05-04 | 2007-05-04 | |
US60/927,785 | 2007-05-04 | ||
US12/114,608 US8002817B2 (en) | 2007-05-04 | 2008-05-02 | Stents with high radial strength and methods of manufacturing same |
US12/114,608 | 2008-05-02 | ||
PCT/US2008/062607 WO2008137821A1 (en) | 2007-05-04 | 2008-05-05 | Stents with high radial strength and methods of manufacturing same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014081475A Division JP5908937B2 (ja) | 2007-05-04 | 2014-04-10 | 半径方向の高い強度を備えたステントおよびその製造方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2010525903A JP2010525903A (ja) | 2010-07-29 |
JP2010525903A5 JP2010525903A5 (ja) | 2011-08-25 |
JP5524829B2 true JP5524829B2 (ja) | 2014-06-18 |
Family
ID=39940140
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010506710A Active JP5524829B2 (ja) | 2007-05-04 | 2008-05-05 | 半径方向の高い強度を備えたステントおよびその製造方法 |
JP2014081475A Active JP5908937B2 (ja) | 2007-05-04 | 2014-04-10 | 半径方向の高い強度を備えたステントおよびその製造方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014081475A Active JP5908937B2 (ja) | 2007-05-04 | 2014-04-10 | 半径方向の高い強度を備えたステントおよびその製造方法 |
Country Status (5)
Country | Link |
---|---|
US (2) | US8002817B2 (ja) |
EP (2) | EP2152207B1 (ja) |
JP (2) | JP5524829B2 (ja) |
HK (1) | HK1186374A1 (ja) |
WO (1) | WO2008137821A1 (ja) |
Families Citing this family (156)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7731890B2 (en) | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US8597716B2 (en) * | 2009-06-23 | 2013-12-03 | Abbott Cardiovascular Systems Inc. | Methods to increase fracture resistance of a drug-eluting medical device |
US8501079B2 (en) | 2009-09-14 | 2013-08-06 | Abbott Cardiovascular Systems Inc. | Controlling crystalline morphology of a bioabsorbable stent |
US8747879B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US7971333B2 (en) | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
US20110066222A1 (en) * | 2009-09-11 | 2011-03-17 | Yunbing Wang | Polymeric Stent and Method of Making Same |
US9517149B2 (en) | 2004-07-26 | 2016-12-13 | Abbott Cardiovascular Systems Inc. | Biodegradable stent with enhanced fracture toughness |
US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
WO2008016578A2 (en) | 2006-07-31 | 2008-02-07 | Cartledge Richard G | Sealable endovascular implants and methods for their use |
US9585743B2 (en) | 2006-07-31 | 2017-03-07 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
US9408607B2 (en) | 2009-07-02 | 2016-08-09 | Edwards Lifesciences Cardiaq Llc | Surgical implant devices and methods for their manufacture and use |
US20130150943A1 (en) | 2007-01-19 | 2013-06-13 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
US8814930B2 (en) | 2007-01-19 | 2014-08-26 | Elixir Medical Corporation | Biodegradable endoprosthesis and methods for their fabrication |
US8182890B2 (en) | 2007-01-19 | 2012-05-22 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
US8303644B2 (en) | 2007-05-04 | 2012-11-06 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
US8388673B2 (en) * | 2008-05-02 | 2013-03-05 | Abbott Cardiovascular Systems Inc. | Polymeric stent |
US8002817B2 (en) * | 2007-05-04 | 2011-08-23 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
US20090062839A1 (en) * | 2007-08-31 | 2009-03-05 | Cook Incorporated | Barbed stent vascular occlusion device |
PL3643273T3 (pl) | 2007-12-14 | 2021-12-06 | Edwards Lifesciences Corporation | Ramka do mocowania płatka dla sztucznej zastawki |
WO2009121048A1 (en) * | 2008-03-28 | 2009-10-01 | Ethicon, Inc. | Method of manufacturing a polymeric stent having a circumferential ring configuration |
US20090287295A1 (en) * | 2008-05-13 | 2009-11-19 | Contiliano Joseph H | Method of Manufacturing a Polymeric Stent with a Hybrid Support Structure |
HUE054943T2 (hu) | 2008-06-06 | 2021-10-28 | Edwards Lifesciences Corp | Kis profilú transzkatéteres szívbillentyû |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US8790387B2 (en) | 2008-10-10 | 2014-07-29 | Edwards Lifesciences Corporation | Expandable sheath for introducing an endovascular delivery device into a body |
US20100244305A1 (en) * | 2009-03-24 | 2010-09-30 | Contiliano Joseph H | Method of manufacturing a polymeric stent having improved toughness |
ES2758798T3 (es) * | 2009-10-06 | 2020-05-06 | Sahajanand Medical Tech Private Limited | Implante vascular biorreabsorbible que tiene tensiones distribuidas homogéneamente bajo una carga radial |
PT2752172T (pt) * | 2010-01-30 | 2016-09-06 | Abbott Cardiovascular Systems Inc | Stents de polímero recuperáveis de esmagamento |
US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
US8795354B2 (en) | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
CN201840555U (zh) * | 2010-03-10 | 2011-05-25 | 谢建 | 一种利于压握的血管支架 |
US8370120B2 (en) | 2010-04-30 | 2013-02-05 | Abbott Cardiovascular Systems Inc. | Polymeric stents and method of manufacturing same |
US8844113B2 (en) * | 2010-04-30 | 2014-09-30 | Abbott Cardiovascular Systems, Inc. | Methods for crimping a polymeric stent scaffold onto a delivery balloon |
US8261423B2 (en) | 2010-04-30 | 2012-09-11 | Abbott Cardiovascular Systems Inc. | Methods for crimping a polymeric stent onto a delivery balloon |
US8752261B2 (en) | 2010-07-07 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Mounting stents on stent delivery systems |
US8539663B2 (en) | 2010-08-23 | 2013-09-24 | Abbott Cardiovascular Systems Inc. | Reducing crimping damage to polymer scaffold |
US20120059451A1 (en) * | 2010-09-08 | 2012-03-08 | Qiang Zhang | Method of Manufacturing a Polymeric Stent Having Reduced Recoil |
US9345602B2 (en) | 2010-09-23 | 2016-05-24 | Abbott Cardiovascular Systems Inc. | Processes for making crush recoverable polymer scaffolds |
US9233014B2 (en) * | 2010-09-24 | 2016-01-12 | Veniti, Inc. | Stent with support braces |
US8595913B2 (en) | 2010-09-30 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Stent crimping methods |
CA2813419C (en) | 2010-10-05 | 2019-12-17 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US20120158123A1 (en) * | 2010-12-15 | 2012-06-21 | Biotronik Ag | Polymer stent |
US9155619B2 (en) | 2011-02-25 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US9199408B2 (en) | 2012-04-03 | 2015-12-01 | Abbott Cardiovascular Systems Inc. | Uniform crimping and deployment methods for polymer scaffold |
US8961848B2 (en) | 2011-04-18 | 2015-02-24 | Abbott Cardiovascular Systems Inc. | Methods for increasing a retention force between a polymeric scaffold and a delivery balloon |
CN103607979B (zh) | 2011-04-18 | 2017-04-12 | 艾博特心血管系统公司 | 用于聚合物支架的均匀卷曲和展开的方法 |
US8966868B2 (en) | 2011-05-09 | 2015-03-03 | Abbott Cardiovascular Systems Inc. | Methods of stabilizing molecular weight of polymer stents after sterilization |
US20120290063A1 (en) | 2011-05-09 | 2012-11-15 | Abbott Cardiovascular Systems Inc. | Method of Increasing Stent Retention of Bioabsorbable Scaffolding with a Sheath |
US8709070B2 (en) | 2011-05-10 | 2014-04-29 | Abbott Cardiovascular Systems Inc. | Bioabsorbable scaffold with particles providing delayed acceleration of degradation |
US8752265B2 (en) | 2011-05-13 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Methods for crimping a polymeric scaffold to a delivery balloon and achieving stable mechanical properties in the scaffold after crimping |
US8545546B2 (en) | 2011-05-13 | 2013-10-01 | Abbott Cardiovascular Systems Inc. | Bioabsorbable scaffolds made from composites |
US8747728B2 (en) | 2011-05-24 | 2014-06-10 | Abbott Cardiovascular Systems Inc. | Method and system for manufacturing a polymer endoprosthesis by injection molding and blow molding |
US9339384B2 (en) | 2011-07-27 | 2016-05-17 | Edwards Lifesciences Corporation | Delivery systems for prosthetic heart valve |
CN102429749A (zh) * | 2011-07-27 | 2012-05-02 | 微创医疗器械(上海)有限公司 | 一种新的生物可降解支架的加工方法 |
US8726483B2 (en) | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
US9180228B2 (en) | 2011-10-03 | 2015-11-10 | Abbott Cardiovascular Systems Inc. | Rubber toughened bioresorbable polymer peripheral scaffolds |
US9827093B2 (en) | 2011-10-21 | 2017-11-28 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9408952B2 (en) * | 2011-11-30 | 2016-08-09 | Abbott Cardiovascular Systems Inc. | Pediatric application of bioabsorbable polymer stents in infants and children with congenital heart defects |
US8840678B2 (en) | 2012-02-10 | 2014-09-23 | Abbott Cardiovascular Systems Inc. | Drug-eluting bioabsorbable renal artery stent for renal cancer and inflammatory disorders |
CA3097321A1 (en) | 2012-02-22 | 2013-08-29 | Edwards Lifesciences Cardiaq Llc | Actively controllable stent, stent graft, heart valve and method of controlling same |
US9839537B2 (en) | 2012-03-07 | 2017-12-12 | Abbott Cardiovascular Systems Inc. | Bioresorbable polymer scaffold treatment of coronary and peripheral artery disease in diabetic patients |
US9517151B2 (en) | 2012-03-30 | 2016-12-13 | Abbott Cardiovascular Systems Inc. | Control of balloon inflation rate during deployment of scaffold |
US9089412B2 (en) | 2012-04-02 | 2015-07-28 | Abbott Cardiovascular Systems Inc. | Multilayer bioabsorbable scaffolds and methods of fabricating |
US9254212B2 (en) | 2012-04-06 | 2016-02-09 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
US9289319B2 (en) | 2012-05-14 | 2016-03-22 | Abbott Cardiovascular Systems Inc. | Flow regulation valve for controlling inflation rate of a balloon deploying a scaffold |
US9283100B2 (en) | 2012-05-16 | 2016-03-15 | Abbott Cardiovascular Systems Inc. | Polymer scaffold with multi-pleated balloon |
US9498359B2 (en) | 2012-07-13 | 2016-11-22 | Abbott Cardiovascular Systems Inc. | Polymer scaffolds for peripheral vessels |
US8968387B2 (en) | 2012-07-23 | 2015-03-03 | Abbott Cardiovascular Systems Inc. | Shape memory bioresorbable polymer peripheral scaffolds |
US9205456B2 (en) | 2012-07-24 | 2015-12-08 | Abbott Cardiovascular Systems Inc. | Modifying polymer properties with penetrants in the fabrication of bioresorbable scaffolds |
US10010436B2 (en) | 2012-09-20 | 2018-07-03 | Dotter Intellectual Pte, Ltd. | Polymeric stent and methods of manufacturing the same |
KR101489263B1 (ko) | 2014-02-26 | 2015-02-04 | 썬텍 주식회사 | 고분자 스텐트의 제조방법 및 폴리락트산 고분자 스텐트 |
US9724219B2 (en) | 2012-10-04 | 2017-08-08 | Abbott Cardiovascular Systems Inc. | Method of uniform crimping and expansion of medical devices |
US9956097B2 (en) | 2012-10-23 | 2018-05-01 | Abbott Cardiovascular Systems Inc. | Methods for vascular restoration therapy |
DE102012220129B4 (de) * | 2012-11-05 | 2022-12-15 | Optimed Medizinische Lnstrumente Gmbh | Stent |
WO2014091438A2 (en) * | 2012-12-12 | 2014-06-19 | Shalya Medical Technologies, (India) Pvt. Ltd | An improved bioresorbable polymeric vascular stent device |
US9440317B2 (en) | 2013-01-07 | 2016-09-13 | Abbott Cardiovascular Systems Inc. | Post-crimping inspection of scaffolds mounted on scaffold delivery systems |
US20140212355A1 (en) | 2013-01-28 | 2014-07-31 | Abbott Cardiovascular Systems Inc. | Trans-arterial drug delivery |
US9744058B2 (en) | 2013-02-14 | 2017-08-29 | Abbott Cardiovascular Systems Inc. | Methods of treatment directed to neointimal proliferation generated by endothelial shear stress patterns from drug-eluting bioresorbable vascular scaffold implantation |
CN105517509B (zh) * | 2013-03-13 | 2017-08-08 | 爱德华兹生命科学卡迪尔克有限责任公司 | 铰接式连合瓣膜支架和方法 |
US9277983B2 (en) | 2013-03-13 | 2016-03-08 | Abbott Cardiovascular Systems Inc. | Drug delivery device for peripheral artery disease |
US9125763B2 (en) | 2013-03-15 | 2015-09-08 | Abbott Cardiovascular Systems Inc. | Stent crimping tool insert, system, and method |
US9364350B2 (en) | 2013-07-09 | 2016-06-14 | Abbott Cardiovascular Systems Inc. | Stent with eased corner feature |
US9345597B2 (en) | 2013-07-09 | 2016-05-24 | Abbott Cardiovascular Systems Inc. | Polymeric stent with structural radiopaque marker |
US9717609B2 (en) | 2013-08-01 | 2017-08-01 | Abbott Cardiovascular Systems Inc. | Variable stiffness stent |
US9549806B2 (en) | 2013-08-12 | 2017-01-24 | Abbott Cardiovascular Systems Inc. | Bioresorbable laryngotracheal stent and methods of treatment |
SG10201805117UA (en) | 2013-08-12 | 2018-07-30 | Mitral Valve Tech Sarl | Apparatus and methods for implanting a replacement heart valve |
US10143572B2 (en) | 2013-09-04 | 2018-12-04 | Abbott Cardiovascular Systems Inc. | Assessment of a drug eluting bioresorbable vascular scaffold |
US20150073535A1 (en) | 2013-09-12 | 2015-03-12 | Abbott Cardiovascular Systems Inc. | Treatment of coronary artery lesions with a scaffold having vessel scaffold interactions that reduce or prevent angina |
CN111419472B (zh) | 2013-11-11 | 2023-01-10 | 爱德华兹生命科学卡迪尔克有限责任公司 | 用于制造支架框架的系统和方法 |
US10098734B2 (en) | 2013-12-05 | 2018-10-16 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
WO2015119653A1 (en) | 2014-02-04 | 2015-08-13 | Abbott Cardiovascular Systems Inc. | Drug delivery scaffold or stent with a novolimus and lactide based coating such that novolimus has a minimum amount of bonding to the coating |
US9510976B2 (en) | 2014-04-29 | 2016-12-06 | Abbott Cardiovascular Systems Inc. | Devices and methods for treatment of the Eustachian tube and sinus cavity |
SG10201809870XA (en) * | 2014-06-02 | 2018-12-28 | Amaranth Medical Pte | Bioabsorbable stents |
US9750622B2 (en) | 2014-06-17 | 2017-09-05 | Abbott Cardiovascular Systems Inc. | High molecular weight polylactide and polycaprolactone copolymer and blends for bioresorbable vascular scaffolds |
US9855156B2 (en) | 2014-08-15 | 2018-01-02 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
US9259339B1 (en) | 2014-08-15 | 2016-02-16 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
US9480588B2 (en) | 2014-08-15 | 2016-11-01 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
US9730819B2 (en) | 2014-08-15 | 2017-08-15 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
US9381103B2 (en) | 2014-10-06 | 2016-07-05 | Abbott Cardiovascular Systems Inc. | Stent with elongating struts |
US9918857B2 (en) | 2015-01-14 | 2018-03-20 | Abbott Cardiovascular Systems Inc. | Scaffold having a shaped strut and methods for shaping scaffold struts |
US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
CN108814780A (zh) * | 2015-02-16 | 2018-11-16 | 上海微创医疗器械(集团)有限公司 | 可降解支架及其制备方法 |
CN104586548A (zh) * | 2015-02-16 | 2015-05-06 | 上海微创医疗器械(集团)有限公司 | 可降解支架及其制备方法 |
US9737368B2 (en) | 2015-02-24 | 2017-08-22 | Abbott Cardiovascular Systems Inc. | System and method for attaching a radiopaque marker bead to an endoprosthesis |
US10792471B2 (en) | 2015-04-10 | 2020-10-06 | Edwards Lifesciences Corporation | Expandable sheath |
US10327896B2 (en) | 2015-04-10 | 2019-06-25 | Edwards Lifesciences Corporation | Expandable sheath with elastomeric cross sectional portions |
CN107708620B (zh) * | 2015-06-11 | 2020-09-11 | 北京阿迈特医疗器械有限公司 | 一种闭环结构的支架、其制备方法及用途 |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
US9908297B2 (en) | 2015-08-20 | 2018-03-06 | Abbott Cardiovascular Systems Inc. | Scaffolds having variable wall thickness |
US10080675B2 (en) | 2015-08-24 | 2018-09-25 | Abbott Cardiovascular Systems Inc. | System and method for conditioning an endoprosthesis |
US20170105856A1 (en) | 2015-10-16 | 2017-04-20 | Abbott Cardiovascular Systems Inc. | Non-circular radiopaque markers and methods for attaching a marker to a scaffold |
US9861507B2 (en) | 2015-12-17 | 2018-01-09 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having modified marker structure near distal end |
US9956099B2 (en) * | 2015-12-17 | 2018-05-01 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having reduced crimp profile and carrying radiopaque markers |
US10143573B2 (en) | 2015-12-17 | 2018-12-04 | Abbott Cardiovascular Systems Inc. | Thin-walled scaffolds having flexible distal end |
CN108882985B (zh) | 2015-12-17 | 2021-08-03 | 雅培心血管系统有限公司 | 薄壁支架 |
US10179043B2 (en) | 2016-02-12 | 2019-01-15 | Edwards Lifesciences Corporation | Prosthetic heart valve having multi-level sealing member |
CR20180410A (es) | 2016-03-24 | 2019-04-01 | Edwards Lifesciences Corp | Sistema de entrega de válvula cardíaca protésica |
US11622872B2 (en) | 2016-05-16 | 2023-04-11 | Elixir Medical Corporation | Uncaging stent |
EP3457985B1 (en) | 2016-05-16 | 2021-02-17 | Elixir Medical Corporation | Uncaging stent |
US11096781B2 (en) | 2016-08-01 | 2021-08-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US10463484B2 (en) | 2016-11-17 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic heart valve having leaflet inflow below frame |
US10973631B2 (en) | 2016-11-17 | 2021-04-13 | Edwards Lifesciences Corporation | Crimping accessory device for a prosthetic valve |
US10603165B2 (en) | 2016-12-06 | 2020-03-31 | Edwards Lifesciences Corporation | Mechanically expanding heart valve and delivery apparatus therefor |
US11185406B2 (en) | 2017-01-23 | 2021-11-30 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11654023B2 (en) | 2017-01-23 | 2023-05-23 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US11013600B2 (en) | 2017-01-23 | 2021-05-25 | Edwards Lifesciences Corporation | Covered prosthetic heart valve |
US10660773B2 (en) | 2017-02-14 | 2020-05-26 | Abbott Cardiovascular Systems Inc. | Crimping methods for thin-walled scaffolds |
CN108464879B (zh) | 2017-02-21 | 2020-04-10 | 上海微创医疗器械(集团)有限公司 | 支架 |
US11135056B2 (en) | 2017-05-15 | 2021-10-05 | Edwards Lifesciences Corporation | Devices and methods of commissure formation for prosthetic heart valve |
EP4427706A2 (en) | 2017-05-22 | 2024-09-11 | Edwards Lifesciences Corporation | Valve anchor and installation method |
US12064341B2 (en) | 2017-05-31 | 2024-08-20 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11026785B2 (en) | 2017-06-05 | 2021-06-08 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US10869759B2 (en) | 2017-06-05 | 2020-12-22 | Edwards Lifesciences Corporation | Mechanically expandable heart valve |
US10918473B2 (en) | 2017-07-18 | 2021-02-16 | Edwards Lifesciences Corporation | Transcatheter heart valve storage container and crimping mechanism |
EP3664749B1 (en) | 2017-08-11 | 2023-07-26 | Edwards Lifesciences Corporation | Sealing element for prosthetic heart valve |
US11083575B2 (en) | 2017-08-14 | 2021-08-10 | Edwards Lifesciences Corporation | Heart valve frame design with non-uniform struts |
US10932903B2 (en) | 2017-08-15 | 2021-03-02 | Edwards Lifesciences Corporation | Skirt assembly for implantable prosthetic valve |
US10898319B2 (en) | 2017-08-17 | 2021-01-26 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10973628B2 (en) | 2017-08-18 | 2021-04-13 | Edwards Lifesciences Corporation | Pericardial sealing member for prosthetic heart valve |
US10722353B2 (en) | 2017-08-21 | 2020-07-28 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10973629B2 (en) | 2017-09-06 | 2021-04-13 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US11147667B2 (en) | 2017-09-08 | 2021-10-19 | Edwards Lifesciences Corporation | Sealing member for prosthetic heart valve |
US10555825B2 (en) | 2017-11-09 | 2020-02-11 | Abbott Cardiovascular Systems Inc. | Rotation of a medical device during crimping |
JP2021074027A (ja) * | 2018-03-13 | 2021-05-20 | テルモ株式会社 | ステントおよびステントの作製方法 |
US11318011B2 (en) | 2018-04-27 | 2022-05-03 | Edwards Lifesciences Corporation | Mechanically expandable heart valve with leaflet clamps |
US10967556B2 (en) | 2018-06-11 | 2021-04-06 | Abbott Cardiovascular Systems Inc. | Uniform expansion of thin-walled scaffolds |
CN112867468B (zh) | 2018-10-19 | 2024-08-23 | 爱德华兹生命科学公司 | 具有非圆柱形框架的假体心脏瓣膜 |
JP2022517423A (ja) | 2019-01-17 | 2022-03-08 | エドワーズ ライフサイエンシーズ コーポレイション | 人工弁用のフレーム |
WO2020198273A2 (en) | 2019-03-26 | 2020-10-01 | Edwards Lifesciences Corporation | Prosthetic heart valve |
DE102019112971A1 (de) * | 2019-05-16 | 2020-11-19 | Optimed Medizinische Instrumente Gmbh | Stent |
GB202005046D0 (en) * | 2020-04-06 | 2020-05-20 | Cambridge Entpr Ltd | Method of additive layer manufacturing |
EP4167911A1 (en) | 2020-06-18 | 2023-04-26 | Edwards Lifesciences Corporation | Crimping methods |
KR20230132822A (ko) | 2021-01-20 | 2023-09-18 | 에드워즈 라이프사이언시스 코포레이션 | 판막엽을 인공 심장 판막의 프레임에 부착하기 위한연결 스커트 |
JP2024097352A (ja) * | 2021-02-19 | 2024-07-19 | テルモ株式会社 | ステント |
EP4312883A1 (en) | 2021-03-23 | 2024-02-07 | Edwards Lifesciences Corporation | Prosthetic heart valve having elongated sealing member |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2247891C (en) * | 1996-03-07 | 2007-07-31 | Med Institute, Inc. | An expandable stent |
US6206911B1 (en) * | 1996-12-19 | 2001-03-27 | Simcha Milo | Stent combination |
US6682554B2 (en) * | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
US6273911B1 (en) * | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6312459B1 (en) * | 1999-06-30 | 2001-11-06 | Advanced Cardiovascular Systems, Inc. | Stent design for use in small vessels |
US6939373B2 (en) * | 2003-08-20 | 2005-09-06 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US20050187615A1 (en) * | 2004-02-23 | 2005-08-25 | Williams Michael S. | Polymeric endoprostheses with enhanced strength and flexibility and methods of manufacture |
US7090694B1 (en) * | 2003-11-19 | 2006-08-15 | Advanced Cardiovascular Systems, Inc. | Portal design for stent for treating bifurcated vessels |
JP4665109B2 (ja) * | 2004-04-02 | 2011-04-06 | アルテリアル リモデリング テクノロジーズ, インコーポレイテッド | ポリマーベースのステントアセンブリ |
US8597716B2 (en) * | 2009-06-23 | 2013-12-03 | Abbott Cardiovascular Systems Inc. | Methods to increase fracture resistance of a drug-eluting medical device |
US20060020330A1 (en) * | 2004-07-26 | 2006-01-26 | Bin Huang | Method of fabricating an implantable medical device with biaxially oriented polymers |
US20110066222A1 (en) * | 2009-09-11 | 2011-03-17 | Yunbing Wang | Polymeric Stent and Method of Making Same |
US7731890B2 (en) * | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US8012402B2 (en) * | 2008-08-04 | 2011-09-06 | Abbott Cardiovascular Systems Inc. | Tube expansion process for semicrystalline polymers to maximize fracture toughness |
US8268228B2 (en) * | 2007-12-11 | 2012-09-18 | Abbott Cardiovascular Systems Inc. | Method of fabricating stents from blow molded tubing |
US7971333B2 (en) * | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
US7875233B2 (en) | 2004-09-30 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a biaxially oriented implantable medical device |
US7914574B2 (en) * | 2005-08-02 | 2011-03-29 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US7476245B2 (en) | 2005-08-16 | 2009-01-13 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
JP4842591B2 (ja) * | 2005-08-25 | 2011-12-21 | 川澄化学工業株式会社 | ステント |
US20070135898A1 (en) | 2005-12-13 | 2007-06-14 | Robert Burgermeister | Polymeric stent having modified molecular structures in the flexible connectors and the radial arcs of the hoops |
US7761968B2 (en) * | 2006-05-25 | 2010-07-27 | Advanced Cardiovascular Systems, Inc. | Method of crimping a polymeric stent |
US20070282433A1 (en) | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US20070290412A1 (en) | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
US7740791B2 (en) * | 2006-06-30 | 2010-06-22 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a stent with features by blow molding |
US8099849B2 (en) * | 2006-12-13 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Optimizing fracture toughness of polymeric stent |
US20130150943A1 (en) * | 2007-01-19 | 2013-06-13 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
US8182890B2 (en) * | 2007-01-19 | 2012-05-22 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
US8388673B2 (en) * | 2008-05-02 | 2013-03-05 | Abbott Cardiovascular Systems Inc. | Polymeric stent |
US8303644B2 (en) * | 2007-05-04 | 2012-11-06 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
US8002817B2 (en) * | 2007-05-04 | 2011-08-23 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
US7666342B2 (en) * | 2007-06-29 | 2010-02-23 | Abbott Cardiovascular Systems Inc. | Method of manufacturing a stent from a polymer tube |
US8252215B2 (en) * | 2008-03-31 | 2012-08-28 | Abbott Cardiovascular Systems Inc. | Method for fabricating a stent with nucleating agent |
US20110260352A1 (en) * | 2010-04-21 | 2011-10-27 | Fuh-Wei Tang | Stabilizing Semi-Crystalline Polymers To Improve Storage Performance Of Medical Devices |
US8808353B2 (en) * | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
US8261423B2 (en) * | 2010-04-30 | 2012-09-11 | Abbott Cardiovascular Systems Inc. | Methods for crimping a polymeric stent onto a delivery balloon |
US8370120B2 (en) * | 2010-04-30 | 2013-02-05 | Abbott Cardiovascular Systems Inc. | Polymeric stents and method of manufacturing same |
US8844113B2 (en) * | 2010-04-30 | 2014-09-30 | Abbott Cardiovascular Systems, Inc. | Methods for crimping a polymeric stent scaffold onto a delivery balloon |
US8539663B2 (en) * | 2010-08-23 | 2013-09-24 | Abbott Cardiovascular Systems Inc. | Reducing crimping damage to polymer scaffold |
US9345602B2 (en) * | 2010-09-23 | 2016-05-24 | Abbott Cardiovascular Systems Inc. | Processes for making crush recoverable polymer scaffolds |
US9199408B2 (en) * | 2012-04-03 | 2015-12-01 | Abbott Cardiovascular Systems Inc. | Uniform crimping and deployment methods for polymer scaffold |
US8752265B2 (en) * | 2011-05-13 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Methods for crimping a polymeric scaffold to a delivery balloon and achieving stable mechanical properties in the scaffold after crimping |
US8747728B2 (en) * | 2011-05-24 | 2014-06-10 | Abbott Cardiovascular Systems Inc. | Method and system for manufacturing a polymer endoprosthesis by injection molding and blow molding |
-
2008
- 2008-05-02 US US12/114,608 patent/US8002817B2/en active Active
- 2008-05-05 EP EP08747619.8A patent/EP2152207B1/en not_active Not-in-force
- 2008-05-05 EP EP12196606.3A patent/EP2604230B1/en not_active Not-in-force
- 2008-05-05 JP JP2010506710A patent/JP5524829B2/ja active Active
- 2008-05-05 WO PCT/US2008/062607 patent/WO2008137821A1/en active Application Filing
-
2011
- 2011-07-22 US US13/189,370 patent/US20110277305A1/en not_active Abandoned
-
2013
- 2013-12-18 HK HK13114007.7A patent/HK1186374A1/zh not_active IP Right Cessation
-
2014
- 2014-04-10 JP JP2014081475A patent/JP5908937B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
WO2008137821A1 (en) | 2008-11-13 |
JP5908937B2 (ja) | 2016-04-26 |
EP2152207B1 (en) | 2013-08-07 |
HK1186374A1 (zh) | 2014-03-14 |
JP2014158945A (ja) | 2014-09-04 |
EP2604230A1 (en) | 2013-06-19 |
EP2152207A1 (en) | 2010-02-17 |
US20080275537A1 (en) | 2008-11-06 |
US8002817B2 (en) | 2011-08-23 |
US20110277305A1 (en) | 2011-11-17 |
JP2010525903A (ja) | 2010-07-29 |
EP2604230B1 (en) | 2016-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5908937B2 (ja) | 半径方向の高い強度を備えたステントおよびその製造方法 | |
US10357384B2 (en) | Radially expandable polymer prosthesis and method of making same | |
US20220226133A1 (en) | Balloon expanded polymer stent | |
US9522503B2 (en) | Methods of treatment with stents with enhanced fracture toughness | |
US9827119B2 (en) | Polymer scaffolds having a low crossing profile | |
WO2007142750A1 (en) | Stent with retention protrusions formed during crimping | |
JP2017527372A (ja) | 生体分解性ポリマーステント骨格パターン |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110413 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110708 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120925 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120928 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121217 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121225 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130124 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130131 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20130225 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130304 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130325 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131001 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131004 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140311 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140410 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5524829 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |